Bruker Total Liabilities 2010-2024 | BRKR
Bruker total liabilities from 2010 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
- Bruker total liabilities for the quarter ending December 31, 2024 were $4.010B, a 40.43% increase year-over-year.
- Bruker total liabilities for 2024 were $4.01B, a 40.43% increase from 2023.
- Bruker total liabilities for 2023 were $2.855B, a 14.85% increase from 2022.
- Bruker total liabilities for 2022 were $2.486B, a 3.09% decline from 2021.
Bruker Annual Total Liabilities
(Millions of US $) |
| 2024 |
$4,010 |
| 2023 |
$2,855 |
| 2022 |
$2,486 |
| 2021 |
$2,565 |
| 2020 |
$2,075 |
| 2019 |
$1,854 |
| 2018 |
$1,224 |
| 2017 |
$1,215 |
| 2016 |
$1,115 |
| 2015 |
$997 |
| 2014 |
$1,093 |
| 2013 |
$1,138 |
| 2012 |
$1,147 |
| 2011 |
$1,086 |
| 2010 |
$1,022 |
| 2009 |
$754 |
Bruker Quarterly Total Liabilities
(Millions of US $) |
| 2024-12-31 |
$4,010 |
| 2024-09-30 |
$4,288 |
| 2024-06-30 |
$4,096 |
| 2024-03-31 |
$3,074 |
| 2023-12-31 |
$2,855 |
| 2023-09-30 |
$2,593 |
| 2023-06-30 |
$2,606 |
| 2023-03-31 |
$2,565 |
| 2022-12-31 |
$2,486 |
| 2022-09-30 |
$2,389 |
| 2022-06-30 |
$2,400 |
| 2022-03-31 |
$2,519 |
| 2021-12-31 |
$2,565 |
| 2021-09-30 |
$2,038 |
| 2021-06-30 |
$2,072 |
| 2021-03-31 |
$2,053 |
| 2020-12-31 |
$2,075 |
| 2020-09-30 |
$1,917 |
| 2020-06-30 |
$2,037 |
| 2020-03-31 |
$2,037 |
| 2019-12-31 |
$1,854 |
| 2019-09-30 |
$1,497 |
| 2019-06-30 |
$1,480 |
| 2019-03-31 |
$1,321 |
| 2018-12-31 |
$1,224 |
| 2018-09-30 |
$1,064 |
| 2018-06-30 |
$1,021 |
| 2018-03-31 |
$1,040 |
| 2017-12-31 |
$1,215 |
| 2017-09-30 |
$1,222 |
| 2017-06-30 |
$1,150 |
| 2017-03-31 |
$1,108 |
| 2016-12-31 |
$1,115 |
| 2016-09-30 |
$1,097 |
| 2016-06-30 |
$1,050 |
| 2016-03-31 |
$1,031 |
| 2015-12-31 |
$997 |
| 2015-09-30 |
$1,075 |
| 2015-06-30 |
$1,053 |
| 2015-03-31 |
$1,051 |
| 2014-12-31 |
$1,093 |
| 2014-09-30 |
$1,098 |
| 2014-06-30 |
$1,119 |
| 2014-03-31 |
$1,159 |
| 2013-12-31 |
$1,138 |
| 2013-09-30 |
$1,156 |
| 2013-06-30 |
$1,079 |
| 2013-03-31 |
$1,119 |
| 2012-12-31 |
$1,147 |
| 2012-09-30 |
$1,104 |
| 2012-06-30 |
$1,109 |
| 2012-03-31 |
$1,135 |
| 2011-12-31 |
$1,086 |
| 2011-09-30 |
$1,067 |
| 2011-06-30 |
$1,069 |
| 2011-03-31 |
$1,052 |
| 2010-12-31 |
$1,022 |
| 2010-09-30 |
$783 |
| 2010-06-30 |
$728 |
| 2010-03-31 |
$742 |
| 2009-12-31 |
$754 |
| 2009-09-30 |
$751 |
| 2009-06-30 |
$751 |
| 2009-03-31 |
$761 |
| Sector |
Industry |
Market Cap |
Revenue |
| Computer and Technology |
Scientific Instruments Manufacturing |
$7.866B |
$3.366B |
|
Bruker Corp designs & manufactures proprietary life science & materials research systems & associated products that serve multiple customers in life science research, pharmaceuticals, applied markets, nanotechnology, cell biology, clinical research, microbiology & in-vitro diagnostics. BSI Life Science reports under two groups: Bruker BioSpin Group & Bruker CALID Group. The Bruker BioSpin comprises the Bruker Magnetic Resonance & Preclinical Imaging divisions, which designs, manufactures & distributes enabling life science tools based on the magnetic resonance technology. The Bruker CALID comprises the Bruker Daltonics & primarily designs, manufactures & distributes life-science mass spectrometry instruments that can be integrated with other sample preparation or chromatography instruments. BSI Nano designs, manufactures & distributes advanced X-ray instruments to determine the characteristics of matter & the three-dimensional structure of molecules.
|
